Log in to save to my catalogue

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a ran...

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a ran...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6269599

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Based on previous findings, we hypothesised that radiotherapy to the prostate would improve overall survival in men with metastatic prostate cancer, and that the benefit would be greatest in patients with a low metastatic burden. We aimed to compare standard of care for metastatic prostate cancer, with and without radiotherapy.
We did a randomis...

Alternative Titles

Full title

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6269599

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6269599

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(18)32486-3

How to access this item